Document is current
Any future updates will be listed below
-
Authors
Dobersch, Stephanie https://orcid.org/0000-0002-6633-4228
Yamamoto, Naomi
Schutter, Aidan https://orcid.org/0009-0006-6585-4308
Cavender, Sarah M.
Robertson, Tess M.
Kartha, Nithya
Samraj, Annie N. https://orcid.org/0009-0001-0599-1144
Doron, Ben
Poole, Lisa A.
Wladyka, Cynthia L.
Zhang, Amy
Jang, Gun Ho
Mahalingam, Aswanth H.
Barreto, Guillermo https://orcid.org/0000-0002-7777-4712
Raghavan, Srivatsan https://orcid.org/0000-0002-5374-9918
Narla, Goutham https://orcid.org/0000-0003-4098-4203
Notta, Faiyaz
Eisenman, Robert N.
Hsieh, Andrew C. https://orcid.org/0000-0002-0897-1050
Kugel, Sita
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (5R37CA241472-03, 1R01CA255015-01, R37 CA230617, K08 CA260442, R37 CA230617, R01 CA276308)
A Swim Across America Pancreas Cancer Development Research Award
Deutsche Forschungsgemeinschaft (465590102)
American Cancer Society (PF-24-1196662-01-RMC)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM135362)
- License Information
-
More Information
Article History
Received: 28 August 2024
Accepted: 14 May 2025
First Online: 26 May 2025
Competing interests
: S.D., N.Y., and S.K. are inventors on a patent application (provisional) filed by Fred Hutchinson Cancer Center directed for the inventions directed to HMGA2’s role in PDAC. S.R. receives research funding from Microsoft and holds equity in Amgen outside the described work. The remaining authors declare no competing interests.
